logo
Plus   Neg
Share
Email

Varian Updates GAAP Results For Q4 & FY19 - Quick Facts

Varian (VAR) updated its previously reported GAAP preliminary financial results for fourth quarter and fiscal 2019. The projected financial performance of the company's recently acquired Endocare and Alicon businesses was better than previously expected, resulting in an increase in the fair value of the contingent consideration payable under earnout obligations to the sellers. The fair value increase has no impact on the previously reported non-GAAP financial results.

The increase in fair value related to the Endocare and Alicon businesses has resulted in an $18.6 million increase in acquisition-related expenses in the fourth quarter of fiscal 2019 and an $18.6 million increase in accrued liabilities as of the end of the fourth quarter of fiscal 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry. Graco Inc. (GGG) shares were climbing more than 7 percent in morning trade. Monday after market close, the company had reported a surge in the fourth-quarter earnings to $84.8 million from $73.7 million in the prior year. Earnings per share surpassed analysts' estimates. Sales were up 1 percent to $412.3...
RELATED NEWS
Follow RTT
>